Wyeth Anticipates “Approvable” Letter For Effexor XR Follow-On
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO Essner says issues at firm’s Puerto Rico manufacturing facility are one reason to expect an approvable letter.
You may also be interested in...
Wyeth’s Pristiq Deemed “Approvable” By FDA
Approval of Effexor XR follow-on is contingent upon inspection of firm's Puerto Rico manufacturing plant.
Wyeth’s Pristiq Deemed “Approvable” By FDA
Approval of Effexor XR follow-on is contingent upon inspection of firm's Puerto Rico manufacturing plant.
Wyeth To Revisit Launch Plans For Effexor XR Follow-On
The company is waiting for results of lower dose desvenlafaxine studies, but says launch plans are not impacted by FDA's review extension.